Celltex adult stem cell therapy helps Multiple Sclerosis patient begin the new year on a strong note

Debbie Bertrand was diagnosed with Multiple Sclerosis (MS) in 2001 after experiencing a number of troubling symptoms that made it difficult for her to walk and use her hands. Eventually dependent upon a wheelchair but unwilling to simply accept her prognosis, Debbie researched different treatment options and even looked into participating in four different stem […]

Continue reading


Stem cells transplantation of neurotrophic factors shows promise in ALS

Researchers in Jerusalem have found that mesenchymal stem cells (MSCs) engineered to secrete neurotrophic growth factors (NTFs), may help to slow the progression of amyotrophic lateral sclerosis (ALS) without lasting and unwanted effects. Researchers found that among the 12 participants of the study, ages 20 through 75, who received a single injection of these MSC-NTFs […]

Continue reading


Celltex SJIA client Sarah Hughes inspires hope at “Be An Angel” charity event

Celltex client, 24-year-old Sarah Hughes, is celebrating her one-year anniversary since receiving adult stem cell therapy. After years of being severely disabled with serious consequences of systemic juvenile idiopathic arthritis (SJIA) and severe dysautonomia, Sarah has undergone a life-changing transformation this year that has astounded her family and physicians. Sarah Hughes wears a designer gown […]

Continue reading


Adult Stem Cell Therapy May Help Raynaud’s Disease

Celltex Recognizes October as Raynaud’s Disease Awareness Month This October marks the first “Raynaud’s Disease Awareness Month” in the United States. Approximately five to 10 percent of all Americans suffer from Raynaud’s disease. The Raynaud’s Association declared October the official awareness month to share information regarding the disease and to highlight the condition on a […]

Continue reading


Adult Stem Cell Therapy May Help Raynaud’s Disease – Celltex Recognizes October as Raynaud’s Disease Awareness Month

This October marks the first “Raynaud’s Disease Awareness Month” in the United States. Approximately five to 10 percent of all Americans suffer from Raynaud’s disease. The Raynaud’s Association declared October the official awareness month to share information regarding the disease and to highlight the condition on a national scale. While this awareness month is new […]

Continue reading


Celltex’s Adult Stem Cell Therapy May Help Those Affected by Dysautonomia

Houston-based biotechnology company recognizes October as Dysautonomia Awareness Month   October is internationally recognized as Dysautonomia Awareness Month and Celltex Therapeutics, a Houston-based biotechnology company, is hoping to raise awareness about the “invisible disease” that affects more than 70 million people worldwide. Dysautonomia is an umbrella term used to describe any disease or illness caused by […]

Continue reading


Celltex Recognizes September as Chronic Pain Awareness Month

September 24, 2015 – In 2001, the American Chronic Pain Association (ACPA) deemed September “Pain Awareness Month” in order to educate the general public about chronic pain and its debilitating effects on those who suffer from pain. The ACPA also hopes to shed light on current pain management options and to make America’s appointed leaders […]

Continue reading


Celltex Director Awarded Procter & Gamble 2015 Alumni Business Innovation Award

Dr. Nabil Sakkab was recently awarded the Alumni BusinessInnovation Award by Procter & Gamble Celltex Director Dr. Nabil Sakkab, was awarded the Alumni Business Innovation Award by Procter & Gamble on May 16, 2015 in Miami, Florida. This prestigious award is granted to an individual who has greatly contributed to the world of business during […]

Continue reading